a public good project by the
Synthesis
Company
of California

© 2026

Antoine Thyss | doi.page

0 works0 citations0 h-index

Antoine Thyss

Centre Antoine Lacassagne(FR)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Neuroblastoma Research and Treatments, CNS Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research

Most-Cited Works

→ Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial(2011)533 cited
→ High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.(1998)329 cited
→ Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.(1995)284 cited
→ Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study(2019)268 cited
→ Influence of sex and age on fluorouracil clearance.(1992)259 cited
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.(1992)

→ Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.(1996)

202 cited

→ N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.(1997)184 cited

→ 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer(1989)173 cited

Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients.(1988)